⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL227972 | 0.97 | ALDH1A1 (0.56) | — | |
| SCHEMBL229257 | 0.97 | ALDH1A1 (0.56) | — | |
| SCHEMBL48352 | 0.97 | ALDH1A1 (0.56) | — | |
| SCHEMBL224023 | 0.94 | — | — | |
| SCHEMBL11844730 | 0.88 | — | — | |
| SCHEMBL8978116 | 0.88 | ALDH1A1 (0.64) | — | |
| SCHEMBL9279972 | 0.88 | ALDH1A1 (0.64) | — | |
| SCHEMBL24693081 | 0.85 | CA2 (0.50) | — | |
| SCHEMBL11742016 | 0.85 | L3MBTL1 (0.52) | — | |
| SCHEMBL2959927 | 0.84 | ALDH1A1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 582 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874601-A | 3, 3-Dimethyl-1, 2,3, 4-tetrahydro-9H-carbazole derivative and preparation method and application thereof | 山东大学 | 2025-04-25 | — | — | CN | claimed |
| CN-106966947-B | A kind of preparation method of vildagliptin | 河北医科大学 | 2019-09-03 | — | — | CN | claimed |
| CN-106117104-B | A kind of preparation method of vildagliptin | 东北制药集团股份有限公司 | 2018-11-20 | — | — | CN | claimed |
| WO-2015150887-A1 | PROCESS FOR THE PREPARATION OF ANAGLIPTIN OR ITS SALTS | WOCKHARDT LIMITED (IN) | 2015-10-08 | — | — | WO | claimed |
| US-12637451-B2 | Amino quinazoline derivatives as P2X3 inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2026-05-26 | — | — | US | disclosed |
| EP-4288426-B1 | QUINOXALINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS INC (US) | 2026-02-04 | — | — | EP | disclosed |
| EP-4676923-A1 | BIARYLAMIDE DERIVATIVES AND THEIR USE AS PKMYT1 INHIBITORS | Cancer Research Technology Limited (GB) | 2026-01-14 | — | — | EP | disclosed |
| US-20250388582-A1 | NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF | ILDONG PHARMACEUTICAL CO LTD (KR) | 2025-12-25 | — | — | US | disclosed |
| US-20250230137-A1 | P300/CBP HAT INHIBITORS | CONSTELLATION PHARMACEUTICALS INC (US) | 2025-07-17 | — | — | US | disclosed |
| US-20250206745-A1 | PYRROLOPYRIDAZINE DERIVATIVES AND RELATED USES | NODTHERA LTD (GB) | 2025-06-26 | — | — | US | disclosed |
| EP-4556476-A1 | NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF | Ildong Pharmaceutical Co., Ltd. (KR) | 2025-05-21 | — | — | EP | disclosed |
| US-20250136598-A1 | SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2025-05-01 | — | — | US | disclosed |
| US-4405623-A | HYPOTENSIVE AGENTS, VASODILATORS | MASAYUKI ISHIKAWA (JP) | 1983-09-20 | — | — | US | disclosed |
| US-4396556-A | REACTING A 2-HALOACETAMIDE WITH A PHOSPHONATE, PHOSPHINATE, OR PHOSPHINE OXIDE IN A TWO-PHASE LIQUID SYSTEM | OCCIDENTAL RESEARCH CORPORATION (US) | 1983-08-02 | — | — | US | disclosed |
| US-4369309-A | HYPOTENSIVE AGENTS; UASODILATION; CARDIOVASCULAR DISORDERS | SS PHARMACEUTICAL CO., LTD. (JP) | 1983-01-18 | — | — | US | disclosed |
| US-4182743-A | CARRIER CONTAINING HYDROGEN PEROXIDE WATER AND HYDROPHILIC STABILIZER | PHILIP MORRIS INCORPORATED (US) | 1980-01-08 | — | — | US | disclosed |
| US-4099954-A | Amide phosphorothiolate herbicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-07-11 | — | — | US | disclosed |
| US-4068070-A | ANGINA PECTORIS | FUJI CHEMICAL INDUSTRY CO., LTD. (JA) | 1978-01-10 | — | — | US | disclosed |
| US-3998808-A | INSECTICIDES, FUNGICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-12-21 | — | — | US | disclosed |
| US-3962247-A | ANGINA PECTORIS | FUJI CHEMICAL INDUSTRY CO., LTD. (JA) | 1976-06-08 | — | — | US | disclosed |